4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-25-002563
Chief Product Strategy Officer gave up 3,326 shares (to pay taxes)
- Chief Product Strategy Officer acquired 7,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kieffer Tara Lynn Chief Product Strategy Officer | 2025-02-12 | Grant or award | +7,500 | 36,805 | D: show line 1 in the form | ||
| Kieffer Tara Lynn Chief Product Strategy Officer | 2025-02-12 | Shares withheld for taxes | −3,326 | $5.59 | $18,592 | 33,479 | D: show line 2 in the form |
Loading xslF345X05/form4.xml…